Skip to content

Total debt at other companies

Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$198.51M-3.4%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$691.72M+334%
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$377.3M+187%
ALN
Alnylam PharmaceuticalsALNY
$263.69M-4.5%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$250.82M+58.6%
Eli Lilly logo
Eli LillyLLY

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.14B+13.0%
Enterprise value$615.92M-22.3%
P/S15.1×-12.2×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%
Debt / equity-0.1×
Current ratio11.3×+8.3×

Where this comes from

Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $15.72M.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wave Life Sciences's total debt?
Wave Life Sciences (WVE) reported total debt of $15.72M in Q1 2026.
How has Wave Life Sciences's total debt changed year-over-year?
Wave Life Sciences's total debt decreased by 33.4% year-over-year, from $23.6M to $15.72M.
What is the long-term trend for Wave Life Sciences's total debt?
Over 5 years (2020 to 2025), Wave Life Sciences's total debt has grown at a -9.5% compound annual growth rate (CAGR), from $29.31M to $17.77M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.